These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38069812)

  • 1. Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses.
    Goulooze SC; Vis PW; Krekels EHJ; Knibbe CAJ
    Expert Rev Clin Pharmacol; 2023; 16(12):1201-1209. PubMed ID: 38069812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Pharmacodynamics and Modeling in Pediatric Drug Development.
    Conklin LS; Hoffman EP; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S87-S94. PubMed ID: 31502687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the viability of long-acting β
    Matera MG; Rinaldi B; Calzetta L; Cazzola M
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):129-136. PubMed ID: 27615145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.
    Mulugeta Y; Barrett JS; Nelson R; Eshete AT; Mushtaq A; Yao L; Glasgow N; Mulberg AE; Gonzalez D; Green D; Florian J; Krudys K; Seo S; Kim I; Chilukuri D; Burckart GJ
    J Clin Pharmacol; 2016 Nov; 56(11):1326-1334. PubMed ID: 27040726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.
    Germovsek E; Barker CIS; Sharland M; Standing JF
    Clin Pharmacokinet; 2019 Jan; 58(1):39-52. PubMed ID: 29675639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
    Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
    Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.
    Chan P; Ding HT; Liederer BM; Mao J; Belloni P; Chen L; Gao SS; Joseph V; Yang X; Lin JS; Mitra MS; Putnam WS; Quartino A; Bauer RN; Pan L
    Clin Transl Sci; 2021 Sep; 14(5):1945-1954. PubMed ID: 34058071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of population PK-PD modelling in paediatric clinical research.
    De Cock RF; Piana C; Krekels EH; Danhof M; Allegaert K; Knibbe CA
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1(Suppl 1):5-16. PubMed ID: 20340012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review.
    Rashed AN; Jackson C; Gastine S; Hsia Y; Bielicki J; Standing JF; Tomlin S; Sharland M
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1099-1106. PubMed ID: 31760892
    [No Abstract]   [Full Text] [Related]  

  • 16. Population Pharmacokinetics and Exposure-Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis.
    Xu Y; Adedokun OJ; Chan D; Hu C; Xu Z; Strauss RS; Hyams JS; Turner D; Zhou H
    J Clin Pharmacol; 2019 Apr; 59(4):590-604. PubMed ID: 30536638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.
    Brussee JM; Calvier EA; Krekels EH; Välitalo PA; Tibboel D; Allegaert K; Knibbe CA
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1235-44. PubMed ID: 27269200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?
    Barker CI; Standing JF; Turner MA; McElnay JC; Sharland M
    Curr Opin Infect Dis; 2012 Jun; 25(3):235-42. PubMed ID: 22517604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for pharmacokinetic analysis in young children.
    Himebauch AS; Zuppa A
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):497-509. PubMed ID: 24517202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.